GeneDx Holdings Corp. (WGS) Financials
WGS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 394.5 million | 187.3 million |
| 2023-12-31 | 473.7 million | 245.7 million |
| 2023-09-30 | 417.3 million | 163.0 million |
| 2023-06-30 | 476.4 million | 180.3 million |
WGS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -16.9 million | -451000 |
| 2023-12-31 | -32.2 million | -912000 |
| 2023-09-30 | -41.1 million | 430000 |
| 2023-06-30 | -56.3 million | 108000 |
WGS Net Income
No data available :(
WGS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 112.9 million | - | 66.1 million |
| 2023-12-31 | 130.1 million | - | 66.6 million |
| 2023-09-30 | 114.3 million | - | 67.6 million |
| 2023-06-30 | 156.7 million | 6.3 million | 69.1 million |
WGS Shares Outstanding
WGS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 443000 | 11.4 million | 38.5 million | - |
| 2023-12-31 | 2.4 million | 10.0 million | 26.6 million | 15.6 million |
| 2023-09-30 | 112000 | 14.3 million | 26.1 million | 16.8 million |
| 2023-06-30 | 2.8 million | 17.1 million | 37.2 million | 15.3 million |
WGS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 62.4 million | 29.4 million |
| 2023-12-31 | 57.4 million | 31.8 million |
| 2023-09-30 | 53.3 million | 28.0 million |
| 2023-06-30 | 48.7 million | 29.9 million |
WGS
Price: $22.39
52 week price:
Earnings Per Share: -4.97 USD
P/E Ratio: -0.11
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Market Capitalization: 514.1 million